| | Pt | Age | Sex | (cm) | (kg) | FBS (mg/dL) | HbA1c (%) | Underlying disease and history of operation | Medications |
| | 1 | 58 | M | 162.0 | 61.0 | 108 | 5.7 | Pituitary adenoma | - |
| | 2 | 43 | F | 150.0 | 45.0 | 86 | NA | Pituitary apoplexy | - |
| | 3 | 65 | M | 163.8 | 72.5 | 112 | 5.6 | Pituitary adenoma, Diffuse large B-cell lymphoma, s/p TSA | Prednisolone |
| | 4 | 52 | F | 161.7 | 65.9 | 108 | 6.4 | Prolactinoma, HTN | ARB, bromocriptine |
| | 5 | 42 | F | 161.8 | 64.6 | 83 | 5.5 | Pituitary adenoma | - |
| | 6 | 22 | F | 161.9 | 50.6 | 100 | NA | Hypogonadotropic hypogonadism | - |
| | 7 | 60 | M | 170.2 | 71.5 | 129 | 5.7 | Pituitary adenoma | - |
| | 8 | 63 | F | 155.3 | 79.3 | 105 | 5.8 | Empty sella syndrome,
PTC, s/p total thyroidectomy | Cal.vit. D, LT4 |
| | 9 | 43 | F | 162.2 | 68.7 | 99 | NA | Prolactinoma | Bromocriptine |
| | 10 | 55 | M | 161.0 | 72.5 | 82 | 6.0 | Pituitary adenoma, s/p TSA | Prednisolone, LT4, cal.vit. D, testosterone |
| | 11 | 33 | F | 157.0 | 44.0 | 88 | NA | Pituitary adenoma, s/p TSA | - |
| | 12 | 52 | F | 160.5 | 72.3 | 121 | 6.4 | Acromegaly, DM, HTN, s/p TSA, | Losartan, thiazide,
metformin, sitagliptin |
| total
12 | 49 ± 12.8 | M/F
(33%/67%) | 160.6 ± 4.9 | 63.9 ± 11.6 | 101.7 ± 15 | 5.9 ± 0.3 | Pituitary adenoma: 6,
s/p TSA: 4,
Prolactinoma: 2, DM: 1,
HTN: 2, | |
|
|
Values are expressed as mean ± standard deviation or number (%). Pt, patients; , height; , weight; FBS, fasting blood sugar; HbA1c, glycated hemoglobin; NA, Not available; Cal.vit.D, calcium vitamin D; DM, diabetes mellitus; HTN, hypertension; LT4, levothyroxine; PTC, papillary thyroid carcinoma; s/p, status post; TSA, transsphenoidal adenoidectomy. |
